Aarti Pharmalabs Limited

Aarti Pharmalabs Limited’s API facility in Maharashtra produces general APIs, corticosteroids, and oncology APIs with US FDA and EU GMP accreditation. It provides regulatory documentation and IPR support for global markets.

Aarti Pharmalabs Limited manufactures up to 4,000 metric tons of caffeine annually at its Tarapur facilities, serving as a preferred global supplier.

Aarti Pharmalabs Limited offers contract development and manufacturing services for small-molecule drug substances, supporting global innovator pharmaceuticals and biotech companies.

The company manufactures API pharmaceutical intermediates for pharmaceutical companies and research labs, ensuring efficacy and no side effects.

Aarti Pharmalabs Limited adheres to globally recognized health and safety practices for employees.

The company aims to minimize its environmental footprint through efficient operations.

The company’s business strategy aligns with the core values of care, integrity, and excellence.

Aarti Pharmalabs Limited (APL):We are a renowned Indian manufacturing company of Pharmaceuticals and Nutraceuticals with a global footprint. We manufacture Generic APIs, Generic intermediates and Xanthine derivatives. Our operations include 2 R&D centers and 6 manufacturing facilities and our 3 cGMP pharmaceutical products manufacturing plants have been successfully audited by USFDA, EUGMP, EDQM, KFDA and COFEPRIS etc.

Aarti Pharmalabs Limited provides API and drug substance manufacturing services in Gujarat and Mumbai for international clients.

The company produces APIs, NCEs, intermediates, and xanthine derivatives for clinical and commercial use, including process R&D, method development, and stability studies.